IRIS
GNECCHI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.882
EU - Europa 2.146
AS - Asia 1.421
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
SA - Sud America 2
Totale 6.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.858
CN - Cina 1.300
IE - Irlanda 813
IT - Italia 370
FI - Finlandia 292
UA - Ucraina 230
DE - Germania 193
SE - Svezia 108
SG - Singapore 53
GB - Regno Unito 45
FR - Francia 37
BE - Belgio 30
CA - Canada 24
JP - Giappone 22
IN - India 19
NL - Olanda 10
MU - Mauritius 9
AU - Australia 6
MY - Malesia 6
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 5
RU - Federazione Russa 4
KR - Corea 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IQ - Iraq 2
MK - Macedonia 2
TW - Taiwan 2
VN - Vietnam 2
ZA - Sudafrica 2
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
MD - Moldavia 1
MN - Mongolia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 6.475
Salva come PNG Salva come JPEG
Città #
Dublin 813
Chandler 686
Nanjing 362
Jacksonville 318
Ashburn 206
Beijing 177
Wilmington 146
Princeton 145
Lawrence 134
Nanchang 131
Helsinki 126
New York 126
Hebei 103
Shenyang 94
Changsha 93
Medford 92
Jiaxing 86
Pavia 80
Ann Arbor 76
Shanghai 76
Hangzhou 62
Boardman 46
Tianjin 42
Milan 37
Singapore 28
Woodbridge 28
Brussels 25
Norwalk 23
Dearborn 22
Falls Church 22
Toronto 21
Fairfield 19
Los Angeles 19
Tokyo 16
Seattle 15
Verona 14
Washington 13
Piscataway 12
Rome 12
Chieti 10
Redwood City 10
Zhengzhou 10
Catanzaro 7
Des Moines 7
Forlì 7
Guangzhou 7
Kunming 7
Pescara 7
Jinan 6
Palermo 6
Pune 6
Utrecht 6
Taizhou 5
Brno 4
Hefei 4
Las Vegas 4
Leuven 4
Mountain View 4
Ningbo 4
Seri Kembangan 4
Berlin 3
Bologna 3
Ferrara 3
Guardiagrele 3
Lahore 3
Naples 3
Padova 3
San Genesio Ed Uniti 3
Seregno 3
St Petersburg 3
Turin 3
Venezia 3
Atlanta 2
Auburn Hills 2
Baghdad 2
Bari 2
Barletta 2
Biassono 2
Bientina 2
Borås 2
Cape Town 2
Chicago 2
Daejeon 2
Desio 2
Dong Ket 2
Eden Prairie 2
Esslingen am Neckar 2
Fairfax 2
Florence 2
Francavilla Al Mare 2
Frankfurt am Main 2
Gunzenhausen 2
Hirakata 2
Houston 2
Hsinchu 2
Lanzhou 2
Lecco 2
Lodi 2
Milazzo 2
Montoro 2
Totale 4.767
Salva come PNG Salva come JPEG
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 214
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 118
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 85
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 81
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 77
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 76
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 71
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 71
Gene and cell-based therapies for heart disease 69
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 69
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 67
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 67
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 67
Impiego di cellule staminali mesenchimali in cardiologia. 67
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 67
Mesenchymal stem cell therapy for heart disease. 66
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 66
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 65
Adult stem cell-based therapy for the heart 65
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 65
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 61
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 61
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 61
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 60
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 60
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 59
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 59
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 58
Mesenchymal stem cell therapy for heart disease. 57
Paracrine mechanisms of mesenchymal stem cells in tissue repair 57
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 57
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 56
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 56
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 56
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 56
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 55
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 54
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 54
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 53
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 52
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 52
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 51
Vascular remodeling in health and disease 50
Endothelium-targeted gene and cell based therapy for cardiovascular disease 50
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 50
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 50
Human fetal mesenchymal stem cells exert more powerful cytoprotective paracrine effects than bone marrow-derived mesenchymal stem cells 49
Long-term clinical outcome after directional coronary atherectomy followed by stem implantation 49
microRNA and Cardiac Regeneration 49
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 49
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 49
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 49
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 49
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 49
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 49
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 49
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 48
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 48
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 48
Injected adult bone marrow-derived stem cells fuse with cardiomyocytes in the infarcted heart 47
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 47
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 47
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 46
Stem cell therapy for heart repair: the paracrine paradigm. 46
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 46
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 46
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 46
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 45
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 45
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 44
Mesenchymal stem cells overexpressing Akt exhibit enhanced glucose transport and resist hypoxia induced apoptosis 43
Donor age negatively influences the cytoprotective paracrine effects exerted by human mesenchymal stem cells 43
Paracrine action accounts for marked protection of ischemic heart by Akt modified mesenchymal stem cells. 43
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 43
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 43
Genetic therapies for cardiovascular diseases: where we are and where we are going 43
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 43
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair 42
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 42
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 42
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 42
Liver X receptors a and b are in vivo pathophysiological regulators of renin 41
Enhancing stem cell therapy efficacy through genetic modification 40
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 40
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 40
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 40
Transplantation of bone marrow-derived cells expressing Akt into infarcted murine heart produces dramatic improvement in cardiac function despite infrequent cellular fusion. 40
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 39
Endothelium targeted gene and cell based therapies for vascular diseases 38
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 38
Early beneficial effects of bone marrow derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction 38
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 38
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 36
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 36
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 36
null 35
Overexpression of Akt in mesenchymal stem cells improves ATP production under hypoxia by increasing glucose uptake and mitochondrial enzymes activity: a possible explanation for increased resistence to apoptosis. 35
Mesenchymal stem cells overesxpressing Akt prevent cardiac metabolic remodelling after infarction. 35
Tuning tissue ingrowth into pro-angiogenic hydrogels via dual modality degradation 35
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 35
Totale 5.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.429 413 585 1 63 9 57 8 73 26 122 65 7
2020/2021582 65 43 17 42 42 78 4 90 41 70 70 20
2021/2022588 6 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/202558 58 0 0 0 0 0 0 0 0 0 0 0
Totale 6.676